PROK
ProKidney Corp. - Class A Ordinary Shares (PROK)
$73
About ProKidney Corp. - Class A Ordinary Shares (PROK)
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Details
Daily high
$0.89
Daily low
$0.71
Price at open
$0.84
52 Week High
$4.44
52 Week Low
$0.46
Market cap
103.1M
Dividend yield
0.00%
Volume
496,798
Avg. volume
1.1M
P/E ratio
-1.27
ProKidney Corp. - Class A Ordinary Shares News
Details
Daily high
$0.89
Daily low
$0.71
Price at open
$0.84
52 Week High
$4.44
52 Week Low
$0.46
Market cap
103.1M
Dividend yield
0.00%
Volume
496,798
Avg. volume
1.1M
P/E ratio
-1.27